ACE inhibitor

(redirected from angiotensin converting enzyme inhibitor)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to angiotensin converting enzyme inhibitor: Angiotensin receptor blocker
  • noun

Synonyms for ACE inhibitor

an antihypertensive drug that blocks the formation of angiotensin II in the kidney, leading to relaxation of the arteries

References in periodicals archive ?
Following absorption, enalapril is hydrolyzed to enalaprilat, which is a more potent angiotensin converting enzyme inhibitor than enalapril; enalaprilat is poorly absorbed when administered orally.
Most patients in the clinical trial supporting effectiveness, referred to as A-HeFT, received, in addition to BiDil or placebo, a loop diuretic, an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker, and a beta blocker, and many also received a cardiac glycoside or an aldosterone antagonist.
In using PRINIVIL, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that PRINIVIL does not have a similar risk.
Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity.
Among specific topics are anti-glaucoma carbonic anhydrase inhibitors as opthalmologic drugs, crystallographic studies of carbonic anydrases from fungal pathogens for structure-assisted drug development, sulfonylated matrix metalloproteinase inhibitors, Clostridium histolyticum collagenase inhibitors in the drug design, angiotensin converting enzyme inhibitors, and inhibitors of histidinol dehydrogenases as antibacterial agents.
Mercaptopropanoyl) indoline-2-carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents.
Companies with key marketed angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (AIIRAs)-including Novartis, Aventis, Merck & Co.
Full browser ?